University of California San Francisco
Give to UCSF
Patients of acute kidney injury might not need as much dialysis as patients with end-stage kidney disease, and might benefit more from weaning off dialysis to avoid risk for heart disease, infection, organ damage and death.
With fentanyl overdose deaths at an all-time high, a successful UCSF-funded pilot project to distribute fentanyl test strips is being expanded by California Gov. Gavin Newsome as part of his plan to address the crisis.
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
Babies who experience malnutrition may also experience worse cognitive development and have higher chances of death.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Three injectable medications, Wegovy, Ozempic and Mounjaro, are often taken as weight management drugs. UCSF health experts weigh in on the benefits and risks of taking the medications for obesity.
UCSF researchers are working across disease specialties. Diabetes researchers are looking at how oncologists use CAR T-cell therapy to reprogram a person’s immune system to attack cancer cells, for example. They hope to similarly reprogram the immune system to fight diabetes.
An Oregon prison is testing a Norwegian-inspired approach to prison reform that’s designed to bring greater humanity to corrections and improve conditions for staff and prison residents. This includes reducing the use of solitary confinement.
Scientist proved for the first time that kidney cells, housed in an implantable device functioning as an artificial kidney, can survive inside the body of an animal.
A brain implant and digital avatar allow a paralyzed stroke survivor to speak with for first time in 18 years with the help of artificial intelligence.
Gal-3C, a galectin-3 inhibitor, shows promise in limiting post-MI scarring, improving cardiac function, and outperforming current therapies.
Study finds DOACs may lower recurrent VTE risk over warfarin in extended treatment. Observational evidence supports DOAC use.
A newly identified platelet factor 4 (PF4) was found to help rejuvenate the old brain and boost the young brain, potentially opening the door to new therapies that aim to restore brain function
Increasing wildfires means there is more wildfire smoke, which is particularly harmful for our bodies.
A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
Toxic dust from artificial stone slabs popular in kitchen countertops in the U.S. is causing a rising numbers in lung disease among stone workers.
